Unal B, Saatcioglu F(2025) Targeting the unfolded protein response for cancer therapy: mitigating tumor adaptation and immune suppression Biomark Res, 13(1), 156 DOI 10.1186/s40364-025-00813-y, PubMed 41372991
Høyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, Peng Q, Wangen-Riise R, Wiig E, Ma LW, Revheim ME, Juzeniene A(2025) Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts J Nucl Med, 66(12), 1956-1963 DOI 10.2967/jnumed.125.270444, PubMed 41043994
Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JIet al.(2025) SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials Lancet Oncol, 26(12), e683-e693 DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689
